BLFS240517P20000
- 0.10
- 0.000.00%
BioLife Solutions Newsroom
Insider Sale: Chief Marketing Officer Todd Berard Sells 10,000 Shares of BioLife Solutions Inc ...
BioLife Solutions(BLFS.US) Officer Sells US$226.7K in Common Stock
$BioLife Solutions(BLFS.US)$ Officer Berard Todd sold 10,000 shares of common stock on May 15, 2024 at an average price of $22.67 for a total value of $226.7K.Source: Announcement What is statement of
Analysts Are Bullish on Top Healthcare Stocks: Fortress Biotech (FBIO), BioLife Solutions (BLFS)
Express News | BioLife Solutions Inc : Maxim Group Raises Target Price to $30 From $25
Express News | BioLife Solutions Inc : Stephens Raises Target Price to $27 From $21
Analysts Offer Insights on Healthcare Companies: Fennec Pharmaceuticals (FENC) and BioLife Solutions (BLFS)
Express News | BioLife Solutions Shares Are Trading Higher After Benchmark Ugpraded the Stock From Hold to Buy and Announced a $25 Price Target
Correction to BioLife Solutions Ratings
"BioLife Solutions Raised to Buy From Neutral by Benchmark" at 7:31 a.m. ET incorrectly stated that BioLife Solutions was raised to buy from Neutral. It was raised to buy from hold.
Express News | BioLife Solutions Inc : Craig-Hallum Raises Target Price to $23 From $21
BioLife Solns Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/13/2024 30.21% Benchmark → $25 Upgrades Neutral → Buy 04/04/2024 14.58% Jefferies → $22 Initiates Cover
Benchmark Upgrades BioLife Solutions to Buy From Hold With $25 Price Target
BioLife Solutions (BLFS) has an average buy rating and a price target range of $20 to $30, according to analysts polled by Capital IQ.
Express News | BioLife Solutions Inc : Benchmark Raises to Buy
Several BioLife Solutions Insiders Sell Shares Sending Potential Negative Signal
BioLife Solutions, Inc. (NASDAQ:BLFS) shareholders may have reason to be concerned, as several insiders sold their shares over the past year. When evaluating insider transactions, knowing whether in
BioLife Solutions | 10-Q: Quarterly report
BioLife Solutions, Inc. (NASDAQ:BLFS) Q1 2024 Earnings Call Transcript
Lake Street Reaffirms Their Buy Rating on BioLife Solutions (BLFS)
Analysts Conflicted on These Healthcare Names: BioNTech SE (BNTX), Xenon (XENE) and BioLife Solutions (BLFS)
BioLife Solutions, Inc. (BLFS) Q1 2024 Earnings Call Transcript
BioLife Solutions, Inc. (BLFS) Q1 2024 Earnings Call Transcript
Express News | BioLife Solutions Inc Q1 Shr View $-0.28 -- Lseg Ibes Data
Express News | BioLife Solutions Inc - Qtrly Shr Loss $0.22